Matrix Capital Management Company, LP

Insider Reports History

Entity
Company
Location
1000 Winter Street, C/O Matrix Capital Management, Waltham, MA
Signature
Matrix Capital Management Company, LP, by: /s/ David E. Goel, its Managing General Partner
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matrix Capital Management Company, LP:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zentalis Pharmaceuticals, Inc. 10%+ Owner Common Stock, par value $0.001 per share 14M $144M $10.29 Jun 20, 2023 Indirect
Aura Biosciences, Inc. 10%+ Owner Common Stock, par value $0.00001 per share (Common Stock) 6.92M $62.3M $9.00 Nov 9, 2023 Indirect

Insider Reports Filed by Matrix Capital Management Company, LP

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AURA Aura Biosciences, Inc. Nov 9, 2023 1 $14M 4 Nov 9, 2023 10%+ Owner
ZNTL Zentalis Pharmaceuticals, Inc. Jun 20, 2023 1 $108M 4 Jun 20, 2023 10%+ Owner
AURA Aura Biosciences, Inc. Dec 5, 2022 1 $15M 4 Dec 7, 2022 10%+ Owner
ZNTL Zentalis Pharmaceuticals, Inc. May 18, 2022 0 $0 3 Jun 3, 2022 10%+ Owner
AURA Aura Biosciences, Inc. Nov 2, 2021 3 $25M 4 Nov 4, 2021 10%+ Owner
AURA Aura Biosciences, Inc. Oct 28, 2021 0 $0 3 Oct 28, 2021 10%+ Owner